news
-
MU2net Available with FFF Fluence Mode
- June 6, 2017
Secondary MU calculation software, MU2net is now upgraded. Its new version allows the dose calculation and modelization of photon beams with FFF fluence (Flattening Filter Free). A beam must be created specifically in the library to specify the NON-STANDARD type for the fluence.
-
Gustave Roussy and DOSIsoft Collaborate on Big Data and Radiomics applied to Radiation Oncology
- May 18, 2017
Gustave Roussy and DOSIsoft SA collaborate on Big Data and Radiomics applied to radiation oncology. DOSIsoft carries out preliminary research and scientific collaborations on quantitative index and biomarker computation from multimodality imaging.
-
IAEA-ICARO2 MEETING
- May 9, 2017
The second International Conference on Advances in Radiation Oncology (ICARO-2)
June 20-23, 2017
IAEA Headquarters
Vienna International Centre (VIC), Vienna, Austria
Booth #M7 -
SFPM ANNUAL MEETING 2017
- May 9, 2017
56th Scientific Days – Annual Meeting of Société Française de Physique Médicale (SFPM)
June 14-16, 2017
Espace tête d’Or, Lyon, France
Booth #10 -
UKRCO 2017
- May 9, 2017
The UK Radiological Congress and Radiation and Oncology Conference (UKRCO)
June 12-14, 2017
Manchester Central Convention Complex, Manchester, UK
Booth #O18 -
SNMMI ANNUAL MEETING 2017
- May 9, 2017
The Society of Nuclear Medecine and Molecular Imaging (SNMMI) Annual Meeting
June 10-14, 2017
The Colorado Convention Center, Denver, Colorado, USA
Booth #908 -
[Poster] Comparison between PTW 2D-array Octavius and EPIbeam Measurements of a Complex Head&Neck VMAT Plan
- May 5, 2017
M. Del Re , Grand Hôpital de Charleroi, Gilly, Belgium
Presented at ESTRO 2017 -
The Netherlands Cancer Institute Selects PLANET® Dose as their Dosimetry Solution for Radionuclide-based Therapies
- April 28, 2017
The Netherlands Cancer Institute (Antoni van Leeuwenhoek) has selected DOSIsoft PLANET® Dose as their dosimetry solution for Selective Internal Radiation Therapies (SIRT) with 90Y-microspheres and new radionuclide therapies, in particular for neuroendocrine tumors using 177Lu-peptide.
-
ESTRO 2017
- April 5, 2017
European SocieTy for Radiotherapy & Oncology (ESTRO) 36 Annual Meeting
May 05-09, 2017
Reed Messe Wien Congress Center, Vienna, Austria
Booth #2950 -
[Article] Predictive Value of Initial FDG PET Features for Treatment Response and Survival in Esophageal Cancer Patients Treated with Chemoradiotherapy using a Random Forest Classifier
- March 10, 2017
Paul Desbordes, Su Ruan, Roman Modzelewski, Pascal Pineau, Sébastien Vauclin et al.
PLoS One. DOI:10.1371/journal.pone.0173208